INS and infection: Therapeutic advancements in the acute phase post-burn, such as early excision and closure of the burn wound, more appropriate infection control and anti-catabolic therapeutic intervention, including beta-adrenergic blockade with propranolol, growth hormone, insulin-like growth factor, oxandrolone, testosterone, and insulin have substantially contributed to significant improvement of morbidity and mortality rates in burn patients during acute hospitalization.